Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Auris Surgical Robotics raised $280M. Pre-money valuation around $1 Billion. Surgical robot said to be targeting lung cancer. Big money in robotics, everyone sleeping on Titan.
What was the board estimating?
U.K. robotics startup rakes in $20.3 million in Series A
http://medcitynews.com/2016/07/u-k-robotics-startup-rakes-20-3-million-series/
*yawn*
nothing exciting going on except to sit back and watch them push through the milestones. Still long but ready for action.
Schwab & Fidelity informed me that while they can exercise the warrant they are unable to remove the US Legend designation; you own shares you won't be able to sell.
Has anyone heard anything further around this with their brokerages? It makes no sense to exercise but rather sell the warrants if this is the case.
I've only been through a few R/S but they have never ended up well for me even if I believed in the company and their product. If Titan were to R/S I would probably sell off before hand based on my prior experiences.
Stealth robotic surgery player Auris to buy minimally invasive micro-cap Hansen for $80M
Not sure if this was posted already...
http://www.fiercemedicaldevices.com/story/stealth-robotic-surgery-player-auris-buys-minimally-invasive-micro-cap-hans/2016-04-20?utm_medium=rss&utm_source=feedly&utm_campaign=rss
Robotic-assisted laparoscopic prostatectomy yields significant cost savings: study
https://www.dotmed.com/news/story/29980
What do you have in mind? All I can think of is they had pre-sub meetings with FDA causing this shift.
They're not required. Most of the large companies have their venture arms investing in several startups and helping them get to a point where they are de-risked enough for acquisition by that company.
Sometimes they are acquired by the company that invested in them and it's a great buy.
Sometimes they are acquired by another company that did not invest in them since the company that did invest in them was not comfortable with the risk yet (they still make money on their equity investment).
Sometimes they do not hit their milestones or remain to risky for too long of a period and the company moves on.
One of these companies or multiple could very well be invested in Titan waiting for them to hit the proper milestones (often post-CE mark) before they pull the trigger.
I agree. I think 510(k) clearance is not out of the picture with no clinical data. Perhaps a clearance with requirement to perform a post-approval clinical follow-up study. It would be to Titan's advantage to run such a study regardless of FDA requirement or not. Not to mention they can collect hospital and economic data in these studies or perhaps a future registry study that supports the cost savings over time to the payers and hospital systems. This coupled with a low capital cost up front could be huge.
Training was one of Intuitive's weak point where lots of physicians (well known physicians) were getting their hands on robots and performing surgery without the proper training and of course resulting in poor results. The machine was blamed and this caused problems.
If Titan continues to implement a proper training program that select physicians to proctor others and ensure that they have performed X amount of procedures and X hours of training before they begin procedures it will be very beneficial.
You have a good point on the acquirer funding these milestones/raises. Follows the trend you see a lot in the private markets of corporate VC providing bridge loans to those companies as they de-risk and navigate the final 1-2 years until approval/market. Then BOOM.
Breaking News: Da Vinci Robot Becomes Sentient, Terrorizes City
http://gomerblog.com/2016/03/da-vinci-robot-becomes-sentient-terrorizes-city/
No mention of Titan... Didn't see this article posted yet.
http://www.fool.com/investing/general/2016/03/18/if-you-love-intuitive-surgicals-stock-should-you-l.aspx
All of the large companies at these events are always going to have the "thunder". Big pocket books = ability to be a main sponsor and plaster their marketing around the event. TITXF will be small potatoes at any of these events for the next few years but packing a strong product.
Not butt hurt - I'm invested in both companies and I've written off the loss of both companies already. Lots of people have lost the same or more money in TITXF than TRXC depending on when they invested. I didn't invest any money in these companies I wasn't okay with 100% losing so no harm or reason to be butt hurt it's just money.
I'm not stating anything about the technology only the way the article was written. Prior successes don't guarantee the ability to have future successes, but the article only calls out failures of previous companies which is all too common in bio tech. Just saying a very similar article could be written about TITXF if the goal was to achieve the same tone. I see applications for both companies in the field though I feel Titan has a stronger technology.
Nothing poorly reflecting on TRXC was really mentioned in that article. Thought it would have more substantial info but it wasted my time. Safestitch/TRXC made some silly decisions in the past with reverse mergers and splits that killed the PPS, but all the directors/management they are referencing and their previous companies that didn't do well is how the game is played - Welcome to the world of Biotech, more so early-stage biotech. It's a gamble.
The article didn't' mention the successful companies that those people worked for and previously launched. A similar article could be written about TITXF here in a few years depending on how things go even though the outlook for us looks bright now. Just something to ground you all in how unpredictable this industry can be. There's also a time and place for a company to go public, a majority that I think should stay private longer (TITXF included).
What a joke of an article with no substantially important information.
And you are? You called Titan a 'Big POS' back in January 2015. Then a week ago you were holding 15k shares long and strong. http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120350618
Thanks for the cheap shares!
Agreed. I actually don't think their website is all that bad besides being "busy" and cluttered with info and pages. I would much rather see the team actually doing meaningful work that brings them closer to commercialization than screwing around with their website.
I have seen many companies with very little information or no website making significant revenue and have also worked on several deals acquiring medical companies that do not even have a website but a strong team and phenomenal product.
Looking forward to some significant growth in the PPS as we continue to hit milestones and deliver.
I get California weather year round and Disneyland fireworks in my backyard. Going to try to make it out to AORN.
Has anyone in the states successfully exercised their warrants and subsequently sold those shares? I would assume no primarily because the warrants have been out of the money this entire time.
Both Schwab and Fidelity think there is a US restriction on the resulting exercised warrant shares that will not allow me to sell them. I can however sell the warrant contract.
Awesome! Let's get rolling for 2016.
Might be at JPM...
I have never been through a successful R/S... stock always tanks afterward. If TITXF did a R/S I would likely sell a majority of my shares beforehand.
Verb more on the radar than Titan.
http://www.fool.com/investing/general/2015/12/22/will-2016-be-intuitive-surgicals-best-year-yet.aspx?source=eptfxblnk0000004
That's fantastic!
Titan could easily be doing what Verb is doing now. There's lots of 'hype' around Verb but that is so much easier to create when there is a supposed product in the works with big companies behind you like JJ & Google. Once they start releasing potential products, the timelines, regulatory hurdles, etc this hype will likely fade. What we can do is continue pushing links and info about Titan to news organizations and posting in comments of articles on Intuitive/SRI/Verb/MIS about Titan (Ex: The wired article on verb). Hopefully this puts TITXF on the radar of some news organizations and readers checking out these articles.
Easter eggs one easter eggs. Screen grabs belows:
http://imgur.com/QYEA3D5
http://imgur.com/cSPRhju
The medical device industry is incredible small but it definitely seems like this market is even smaller. Nice to see a lot of talent jumping around between all the companies and healthy competition. Would definitely be interesting to pick their brains. Employees are usually more than willing to have a chat with students more so than individuals working at other companies ;)
I'm still not feeling the JJ,Verb,SRI M&A though.
100% agreed - Titan is still pushing along and meeting all of their milestones as it gets closer to coming out with a fantastic product. This partnership has changed the field a little bit and if anything lights a fire under Titan to move along faster.
Is there any "definitive" idea on what verb/JnJ/Google plan to produce. The product could not even be close to competing against Titan or Intuitive especially with Google in the mix.
Lots of theories getting thrown around. As I've also said before, the earliest I expect an acquisition is post-CE mark when the company/product are further de-risked. There are still a lot of suitors out there with a lot of cash and will be looking to enter this market given the tremendous growth potential ;)
Several of the physicians I know that are "faces" of Intuitive and have many papers published around them have heard of Titan but know nothing of them further or their progression. A lot of this is driven from them being such a small player and no public information released and them being Da Vinci users for SO many years. Titan invited these physicians to their offices 5-6 years ago but they were even more insignificant at this time and the physicians were unimpressed. There are a select few that recognize the shortfalls in Da Vinci and seek out information through their own research.
Lots has changed over the years. It blows me away that these physicians are barely aware of Titan. Hopefully some increase PR, the training courses, and completed units will start to put Titan on the map. I know it will happen, just takes time and strategy.
Agreed. Don't think he may bash it, but may take a lot for him to mention it or even praise it. Most surgeons I know that have been heavily invested and involved with Intuitive from the begging are 55+ years old. Most of these surgeons are not going to be willing to train on a new system and switch. Their happy with the results they are getting now, they're making money, and will probably retire before TITXF gets a strong hold on the market. These are all institutions that can afford the Da Vinci where I think TITXF will be targeting a different market and should perhaps look into physicians that are up and coming and out of school.
Nice work!! Hopefully something comes of this. Titan should have been managing all this on their own from the beginning.
THE REGULATORY
PERSPECTIVE
Day 1 | 2:30 - 4:00 PM
Dennis Fowler, Executive Vice
President, Titan Medical Inc.;
GREAT News!! Hadn't checked the board all day so it was nice to see this PR. Looking forward to pushing through Q4 and what FY16 has to come.
NFLX hovering 120
I believe it to be part of the human feasibility trial and clinical trial commencement will remain in Q3.
Can you please provide a link to this info? I'm not seeing any documents on SEDAR as of today.